Sunday, November 11, 2012

Saturday, November 10, 2012

A MotherHood Experience: Sears Portrait Studio Experience

It's hard to believe we are already in the midst of November, only two more months left until the new year! We are already thinking ahead for the upcoming holiday season including decorating ideas, thinking up holiday feasts, gift giving ideas, sending out annual greeting cards and of course family holiday photos!

We all know holiday photo shoots are a great way to make new memories and share them with family and friends in an ever lasting professional photo - we just haven't ever had them done before!

This year will be our first holiday photo shoot and we are super excited to be having them done courtesy of Sears Canada! Sears Canada invited us to make a lasting memory with our family in the Sears Portrait Studio! I admit, we really should have done more of these sooner.

Holiday shopping

Now, before heading off to get our smiles on we needed to dress the kids up a little. As cute as they already are, holiday portraits are all the cuter with the proper attire. We decided to head on into our local Sears location and take advantage of the Sears kids clothing sale! I had posted about it previously via Facebook and Twitter!

Everything dress wear was on sale from Baby to Teen, for 25% off so we were able to dress both kids for less! Sears Canada has lovely dresses in a wide variety of colours and styles for girls and cute, stylish outfits and simple shirt-tie sets for boys. From casual to more fancy, it was hard to decide what to buy for our two little munchkins. Although we were tempted to go fancy (little guy found a really cute shirt and tie set) we decided to go with a dressy-casual look for the kids. Our daughter chose a nice dress and our son a sweater with new jeans to match. They can also wear these outfits after the holidays too!

The photo shoot

Sears Portrait Studio makes it easy to book an appointment online, by phone or even just walk-in for us busy on the go moms! I booked our appointment for a Sunday morning, but unfortunately it was re booked to next week so please, stay tuned for an update including our family photos!

This will be our first time at a professional photo shoot as I said, everyone is excited (some of us may be anxious) and can't wait to share with all of you! Our kids are used to having their pictures taken by us being a little older but for those of you with babies and younger kids who can't sit still or you're afraid won't co operate, the photographers at Sears Portrait Studios are known to be great at helping get the perfect smiles from your little ones! The best photos are always ones when you are relaxed and yourselves.

Our holiday photo session comes with 10 photo cards to share with family and friends, those are going to make a nice finishing touch to our holiday gifts this year!

Keep up to date with everything Sears Canada by following @SearsCa on Twitter and liking the Sears Canada Facebook page! You can also find great promotions and sales online at www.sears.ca!?

The Giveaway

We want you to make ever lasting memories this holiday season with Sears Canada Portrait Studio. One lucky Canadian AME reader has the chance to win their very own FREE portrait session (voucher) courtesy of Sears Canada and MomCentral Canada! Not only that but winner will also receive a SECOND FREE portrait session (voucher) to share with family and friends!?


Giveaway open to CANADIAN residents only. Entering this giveaway on multiple blogs is OK but you can only win the prize once! Ends November 23rd, 2012! GOOD LUCK!

a Rafflecopter giveaway

Disclosure: Posted by AME in participation with Sears The Baby's Room Ambassador program with Mom Central Canada. Special perks are received in affiliation with this group which do not reflect the overall opinions and comments on this blog which are those of the author. Giveaway prize provided by MomCentral Canada.?

Source: http://www.amotherhoodexperience.com/2012/11/MCSearsBRNov.html

paul george eddie long ufc 143 weigh ins micron ceo glenn miller who do you think you are superpac

Home Based Business University - Internet Radio

  • Loading

    On his show, Comedian Rodney Perry covers arts and entertainment, everything from comedy and politics to music and acting, with his signature comedic slant.

  • MashUp Radio is a 30-minute podcast that discusses the fusion of technology, life, culture and science. Host Peter Biddle, engineer and executive for Intel?s Atom Software, dishes up a thought-provoking discussion.

  • Deepak Chopra Radio provides an online forum for compelling and thought provoking conversations on success, love, sexuality and relationships, well-being and spirituality.

  • The Bottom Line Sports Show is hosted by former NBA stars Penny Hardaway, Charles Oakley, Mateen Cleaves. Tune in to get the inside scoop on what's happening in sports today.

  • Joy Keys provides her listeners with insight to improve their lives mentally, physically, monetarily and emotionally. Past guests on the show have included Meshell Nedegeocello, Blair Underwood, in addition to an impressive list of CEOs, humanitarians and authors.

  • Hits Radio covers basketball, sports culture and entertainment with past guests including Jason Kidd, Robin Lundberg and Chris Herren.

  • Listeners get an earful on The Halli Casser-Jayne Show, Talk Radio for Fine Minds. Whether it?s the current political cocktail or the latest must-read award-winning book, Halli tackles all topics and likes to stir ? and sometimes shakes ? things up.

  • Award-winning World Footprints is a leading voice in socially responsible travel and lifestyle. Hosts Ian & Tonya celebrate culture and heritage and bring a unique voice to the world of travel.

  • Football Reporters Online is a group of veteran football experts in the fields of coaching, scouting, talent evaluation, and writing/broadcasting/media placement. Combined, the group brings well over 100 years of expertise in sports.

  • Host John Martin interviews the nation's leading entrepreneurs and small biz experts to educate small business owners on how to be successful. Past guests have included Emeril Lagasse and Guy Kawasaki.

  • The Movie Geeks share their passion for the art through interviews with the stars of and creative minds behind your favorite flicks and pay tribute to big-screen legends. From James Cameron and Francis Ford Coppola to Ellen Burstyn and Robert Duvall, The Geeks have got'em all.

  • Sylvia Global presents global conversations pertaining to women, wealth, business, faith and philanthropy. Sylvia has interviewed an eclectic mix from CEOs and musicians to fashion designers and philanthropists including Randolph Duke and Ne-Yo.

  • Seasoned entertainment reporter Robin Milling gets up close and personal with the world's most compelling celebs. From Michael Douglas to Katie Holmes to Kevin Kline to Ashley Judd to America Ferrera, she sits down in person each week with each and every A-lister.

  • Mr. Media host Bob Andelman goes one-on-one with the hottest, most influential minds from the worlds of film, TV, music, comedy, journalism and literature. That means A-listers like Kirk Douglas, Christian Slater, Kathy Ireland, Rick Fox, Chris Hansen and Jackie Collins.

  • Paula Begoun, best-selling author of Don't Go to the Cosmetics Counter Without Me, separates fact from fiction on achieving a radiant, youthful complexion at any age. She?s regularly joined by health and beauty experts who offer the latest on keeping your skin in tip-top shape.

  • Source: http://www.blogtalkradio.com/homebasedbusinessuniversity/2012/11/09/home-based-business-university

    national enquirer kate gosselin

    A look at Syrian president's statements on crisis

    President Bashar Assad has rarely deviated from his statements on the crisis in Syria since it began nearly 20 months ago. Here is a look at his latest remarks, in an interview shown Friday by broadcaster Russia Today:

    ? "We do not have a civil war."

    Assad has insisted the revolt against his rule is the work of what he calls foreign terrorists ? hostile countries and extremists who want to destroy Syria.

    The uprising began with months of protests by ordinary citizens that turned violent after repeated attacks by security forces. On July 15, the International committee of the Red Cross said it considers the conflict to be a full-blown civil war. That term allows parties involved to use appropriate force to achieve their aims under international humanitarian law.

    ? "I can tell (you) that in weeks we can finish everything."

    Assad has said his military would be able to restore calm quickly ? but only if foreign countries immediately stop sending weapons and aid to the rebels.

    Foreign countries, including nations in the West, Europe and the Gulf, do support the opposition, although most have said they won't arm the rebels out of fear the weapons could fall into the wrong hands. Weapons are being smuggled in, however, although the rebels say they are only getting light arms that cannot turn the tide against the regime's far superior firepower.

    ? "I think that the cost of foreign invasion of Syria, if it happened, would be greater than the whole world can afford."

    Assad has warned against foreign military intervention before, saying any attempt to meddle in the crisis would cause the entire region to burn.

    The conflict does have the potential to suck in neighboring countries because Syria has a web of allegiances to powerful forces, including Iran and the Shiite militant group Hezbollah in Lebanon. But world powers have shown no appetite for military intervention, and even Assad acknowledges it's an unlikely scenario.

    ? "We are the last bastion of secularism, stability and coexistence in the region."

    Syria is too wracked by conflict to be seen as a bastion of stability and coexistence, but it's true that the country has pushed a secular identity in the past. In many ways, it was a strategy to hold together the country's fragile jigsaw puzzle of Sunnis, Shiites, Alawites, Christians, Kurds, Druse, Circassians, Armenians and others.

    Sectarian violence is widely feared, and in a worst-case scenario, the country could descend into warfare among religious sects. The Assad regime is dominated by the Alawite minority, an offshoot of Shiite Islam, but the country is overwhelmingly Sunni Muslim. The uprising already has brought sectarian tensions to the surface.

    Source: http://news.yahoo.com/look-syrian-presidents-statements-crisis-180931224.html

    lance armstrong Iron Man 3 marco scutaro Kendrick Lamar Russell Means Taylor Swift Red Walking Dead Season 3 Episode 2

    Fatherhood, Formula and Other F Words by anhanninen ...

    Fatherhood, Formula and Other F Words by anhanninen (@anhanninen) ~?Complete

    Summary: When man-whore, foul-mouthed Edward?s life takes an unexpected turn, he?s left with a baby to raise. With the help of a friendly neighbor, he learns sometimes the unexpected could be the best thing that?s ever happened

    Banner by IllicitWriter

    Read, Review, Recommend ?

    Don?t forget to read the sequel ??. A Few More F Words

    Summary: Five year old Sofia is starting school and Edward can?t help but feel his baby is growing up too fast. While he and Bella try to juggle a hyper little girl, careers, and their relationship, they find out their lives are about to change drastically once more.

    Banner by IllicitWriter

    Read, Review, Recommend ?

    Like this:

    Be the first to like this.

    November 9, 2012 - Posted by imarieswancullen | 100K - 150K, All Human, Canon, Complete, Daddy/DILFward, Doc/Paramedicward, Drama, EdwardxBella, Family, Friendship, HEA, Humour, IMarieSwanC TBR List, Jerkward, Momella, Multi-Chapter, Playboyward, Rated-M, Romance, Smut/Lemons, Sweetward, Teacher/Professorella | anhanninen, Fanfiction, Rec, Twilight

    No comments yet.

    Source: http://twifanfictionrecs.com/2012/11/09/fatherhood-formula-and-other-f-words-by-anhanninen-anhanninen-complete/

    acm awards 2012 january jones ncaa final game reba mcentire acm awards the killing april fools

    Friday, November 9, 2012

    PREMIUM WordPress Video Themes To BUZZ ... - Web-development

    PREMIUM WordPress Video Themes To BUZZ Your Product Marketing - Professional and High Converting WordPress Themes -Killer WP Templates.comClick Image To Visit SiteBefore you read whole of this letter? I want you to know that I?m NOT selling a "How To" product to make money fast in here!! But I?m providing you a?POWERFULL tool to make you have?BIG?opportunity?to skyrocket your bussiness to make?MORE MONEY.

    Selling products using VIDEO sales is the highest-converting method! And we all know that Video is one of your GRATEST marketing tools ? Period!

    Video can personally engaging your site visitors in ways that will let them watch, read, listen & interact with your message while at the same time persuading and convincing them to take action, opt-in, or even buy your product right now.

    Whether you plan on using video in your sales letter or marketing campaign, you MUST to believe that?

    But, before you start panicking because you have no idea how to get an INCRIDIBLE marketing gun using video, just relax because you are going to get everything you need to put up a video sales on the Internet, and you will amaze yourself how easy it is.

    Today I bring to you something different, a very ideal wordpress themes that can sky rocket your bussiness and product sales, and it can be implemented in just a few minutes ?

    I have designed, for your pleasure and profits, the Revolutionary WordPress Theme to BUZZ your marketing for your product/service?

    Video Press Theme was created with every internet marketer in mind. The Video Press Theme allows you to use the full power of WordPress to create a great looking, high converting, video sales or video presentasion pages with just a few clicks of your mouse.

    They Say A Picture Is Worth A Thousand Words, Right..? So Let See What Video Press Theme Can Do Please Looking In Details?

    Get started in few minutes! Video Press Theme is easy to install and easy to work with. Just activate your WordPress Video Theme, follow the instruction? and start make your attractive video presentation.

    This Video Press Theme comes with very SEXY and PROFESSIONAL design, ready to buzz your marketing product and skyrocket your bussiness. We design the best converting Product Review WordPress themes ever.

    HONESTLY I can say that this Video Press Theme is really EASY to cuztomize each features. Just need to click..click..click.. from theme option, and you can make customizeable video sales page or video presentation? It?s up to you :)

    Video Press Theme built-in with "Go Viral" social share feature that will make your page more socialize. It?s also has a video VOTE button to let your visitors give their vote if they?re Like or Dislike your video/offer. Its will make your site more socialize :)

    Get this AWSOME theme with just one-time payment. You can use it for UNLIMITED website you own? or even use it for your client job, NO Need to pay more for this. Believe me? your client will falling in LOVE with this theme and it?s features. :)

    As you can see? The HARDWORK has been DONE for you..!!?and now it?s your turn to get profits soon.

    It?s a really NO-BRAINER! Time is money, and you need your offer up and running today. These video press theme will help you do that, and they are designed to be successful and get the highest conversion.

    This?Video Press Theme?is a really Revolutionary WordPress Theme for EVERY marketers who want to skyrocket their business and boost their profits using the power of video. It?s so simply and easy to configure, it has a clean and professional layout that beautiful to the visitor eye. And the best part is? it?s?will CONVERT your visitor to the BIG MONEY!

    You will also provided with a video installation and?tutorial guide,?so you can have it all running within few minutes. And, you get the theme totally with zero risk-with my unconditional?30 days money back guarantee!!?

    It?s an honor for me to continue to build products that help people to get their bussiness more success?with ease.

    P.S. Remember, the Video Press Theme is guaranteed to make creating video sales/presentation page as easy as click..click..clik..!!? You must be absolutely delighted with the Video Press Theme, or I?ll rush you a 100% refund right away.

    P.S.S. What do you have to lose? Creating a video sales/presentation has never been easier than buying a copy of the other Premium Video WordPress Theme! Read more?

    Source: http://webdiana.net/computers/premium-wordpress-video-themes-to-buzz-your-product-marketing-professional-and-high-converting-wordpress-themes-killer-wp-templates-com.html

    romney tax return the tree of life movie academy award nominees 2012 2012 oscar nominations kyle williams florida debate rand paul

    Wednesday, November 7, 2012

    Bone marrow stem cells do not improve short-term recovery after heart attack

    Bone marrow stem cells do not improve short-term recovery after heart attack [ Back to EurekAlert! ] Public release date: 7-Nov-2012
    [ | E-mail | Share Share ]

    Contact: Deborah Mann Lake
    deborah.m.lake@uth.tmc.edu
    713-500-3030
    University of Texas Health Science Center at Houston

    UTHealth part of study sponsored by National Heart, Lung, and Blood Institute

    HOUSTON (Nov. 7, 2012) Administering stem cells derived from patients' own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health (NIH).

    The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute.

    The findings were presented Nov. 6, 2012, at the American Heart Association 2012 Scientific Sessions in Los Angeles and appeared concurrently in the Journal of the American Medical Association.

    "These cells, while safe, were not better than placebo solution in providing benefit," said Lemuel Moy, III, M.D., Ph.D., principal investigator of the CCTRN and professor of biostatistics at The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston (UTHealth). "While this one cell type showed little promise, there are several new cell types that are available and we will be studying them. Cell therapy can and likely will play a major role in the treatment of cardiovascular disease in the future."

    "This study was extremely valuable even though it did not provide a demonstrated health benefit after six months," said Sonia Skarlatos, Ph.D., deputy director of NHLBI's Division of Cardiovascular Sciences and member of the CCTRN. "Heart stem cell therapy research is still in its infancy, and results from early trials have varied greatly due to differences in the numbers of stem cells injected, the delivery methods used, and the compositions of the study populations. With TIME and LateTIME, we have established both safety and baseline results in two large studies that followed the same procedures for growing and then administering stem cells. This standard will inform the next steps in research on the use of stem cells to repair damaged hearts."

    Skarlatos noted that another advantage of the TIME study is that CCTRN is storing samples of the stem cells taken from the participants. Investigators can examine the relationship between people who showed significant improvement during the study and the characteristics of their stem cells. Such a comparison may offer insights on the cell traits that are associated with clinical improvement.

    Between July 2008 and February 2011, TIME researchers enrolled 120 volunteers (average age 57, 87.5 percent male) who suffered from moderate to severe impairment in their left ventricles the part of the heart that pumps oxygen-rich blood to the body and had undergone stenting procedures following heart attacks. Those selected for the trial were assigned randomly to one of four groups: day three after heart attack stem cell injection, day three after heart attack placebo injection, day seven after heart attack stem cell treatment, or day seven after heart attack placebo treatment. The researchers developed a method of processing and purifying the stem cells to ensure that participants in the stem cell groups received a uniform dose of 150 million cells about eight hours after the cells were harvested from their bone marrow. This ensured that results would not be skewed by differences in the quantity or quality of stem cells administered.

    Researchers assessed heart improvement six months after stem cell therapy by measuring the percentage of blood that was pumped out of the left ventricle during each contraction (known as the left-ventricular ejection fraction, or LVEF). The study found no significant differences between the change in LVEF readings at the six-month follow-up in either the day three or the day seven stem cell groups compared with placebo groups or with each other. Every group showed about a three percent improvement in LVEF.

    ###

    The National Heart, Lung, and Blood Institute (NHLBI) is a component of the National Institutes of Health. NHLBI plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at: www.nhlbi.nih.gov.

    About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

    UTHealth: The University of Texas Health Science Center at Houston (UTHealth), the most comprehensive academic health center in The UT System and the U.S. Gulf Coast region, is home to schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. UTHealth educates more healthcare professionals than any health-related institution in the State of Texas and features the nation's seventh-largest medical school. It also includes a psychiatric hospital and a growing network of clinics throughout the region. The university's primary teaching hospitals include Memorial Hermann-Texas Medical Center, Children's Memorial Hermann Hospital and Lyndon B. Johnson General Hospital. For more information, visit www.uth.edu.



    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    Bone marrow stem cells do not improve short-term recovery after heart attack [ Back to EurekAlert! ] Public release date: 7-Nov-2012
    [ | E-mail | Share Share ]

    Contact: Deborah Mann Lake
    deborah.m.lake@uth.tmc.edu
    713-500-3030
    University of Texas Health Science Center at Houston

    UTHealth part of study sponsored by National Heart, Lung, and Blood Institute

    HOUSTON (Nov. 7, 2012) Administering stem cells derived from patients' own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health (NIH).

    The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute.

    The findings were presented Nov. 6, 2012, at the American Heart Association 2012 Scientific Sessions in Los Angeles and appeared concurrently in the Journal of the American Medical Association.

    "These cells, while safe, were not better than placebo solution in providing benefit," said Lemuel Moy, III, M.D., Ph.D., principal investigator of the CCTRN and professor of biostatistics at The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston (UTHealth). "While this one cell type showed little promise, there are several new cell types that are available and we will be studying them. Cell therapy can and likely will play a major role in the treatment of cardiovascular disease in the future."

    "This study was extremely valuable even though it did not provide a demonstrated health benefit after six months," said Sonia Skarlatos, Ph.D., deputy director of NHLBI's Division of Cardiovascular Sciences and member of the CCTRN. "Heart stem cell therapy research is still in its infancy, and results from early trials have varied greatly due to differences in the numbers of stem cells injected, the delivery methods used, and the compositions of the study populations. With TIME and LateTIME, we have established both safety and baseline results in two large studies that followed the same procedures for growing and then administering stem cells. This standard will inform the next steps in research on the use of stem cells to repair damaged hearts."

    Skarlatos noted that another advantage of the TIME study is that CCTRN is storing samples of the stem cells taken from the participants. Investigators can examine the relationship between people who showed significant improvement during the study and the characteristics of their stem cells. Such a comparison may offer insights on the cell traits that are associated with clinical improvement.

    Between July 2008 and February 2011, TIME researchers enrolled 120 volunteers (average age 57, 87.5 percent male) who suffered from moderate to severe impairment in their left ventricles the part of the heart that pumps oxygen-rich blood to the body and had undergone stenting procedures following heart attacks. Those selected for the trial were assigned randomly to one of four groups: day three after heart attack stem cell injection, day three after heart attack placebo injection, day seven after heart attack stem cell treatment, or day seven after heart attack placebo treatment. The researchers developed a method of processing and purifying the stem cells to ensure that participants in the stem cell groups received a uniform dose of 150 million cells about eight hours after the cells were harvested from their bone marrow. This ensured that results would not be skewed by differences in the quantity or quality of stem cells administered.

    Researchers assessed heart improvement six months after stem cell therapy by measuring the percentage of blood that was pumped out of the left ventricle during each contraction (known as the left-ventricular ejection fraction, or LVEF). The study found no significant differences between the change in LVEF readings at the six-month follow-up in either the day three or the day seven stem cell groups compared with placebo groups or with each other. Every group showed about a three percent improvement in LVEF.

    ###

    The National Heart, Lung, and Blood Institute (NHLBI) is a component of the National Institutes of Health. NHLBI plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at: www.nhlbi.nih.gov.

    About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

    UTHealth: The University of Texas Health Science Center at Houston (UTHealth), the most comprehensive academic health center in The UT System and the U.S. Gulf Coast region, is home to schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. UTHealth educates more healthcare professionals than any health-related institution in the State of Texas and features the nation's seventh-largest medical school. It also includes a psychiatric hospital and a growing network of clinics throughout the region. The university's primary teaching hospitals include Memorial Hermann-Texas Medical Center, Children's Memorial Hermann Hospital and Lyndon B. Johnson General Hospital. For more information, visit www.uth.edu.



    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    Source: http://www.eurekalert.org/pub_releases/2012-11/uoth-bms110712.php

    last house on the left last house on the left rich forever mixtape blow the unit bob weston bill obrien

    Is your memory playing tricks on you? Check your medicine cabinet!

    Is your memory playing tricks on you? Check your medicine cabinet! [ Back to EurekAlert! ] Public release date: 6-Nov-2012
    [ | E-mail | Share Share ]

    Contact: William Raillant-Clark
    w.raillant-clark@umontreal.ca
    514-343-7593
    University of Montreal

    National Senior Safety Week Drug safety for seniors

    This press release is available in French.

    Common medication to treat insomnia, anxiety, itching or allergies can have a negative impact on memory or concentration in the elderly, according to Dr. Cara Tannenbaum, Research Chair at the Institut universitaire de griatrie de Montral (IUGM, Montreal Geriatric University Institute) and Associate Professor of Medicine and Pharmacy at the University of Montreal (UdeM). Up to ninety percent of people over the age of 65 take at least one prescription medication. Eighteen percent of people in this age group complain of memory problems and are found to have mild cognitive deficits. Research suggests there may be a link between the two.

    Dr. Tannenbaum recently led a team of international researchers to investigate which medications are most likely to affect amnestic (memory) or non-amnestic (attention, concentration, performance) brain functions. After analyzing the results from 162 experiments on medications with potential to bind to cholinergic, histamine, GABAergic or opioid receptors in the brain, Dr. Tannenbaum concluded that the episodic use of several medications can cause amnestic or non-amnestic deficits. This potential cause is often overlooked in persons who are otherwise in good health.

    The 68 trials on benzodiazepines (which are often used to treat anxiety and insomnia) that were analyzed showed that these drugs consistently lead to impairments in memory and concentration, with a clear dose-response relationship. The 12 tests on antihistamines and the 15 tests on tricyclic antidepressants showed deficits in attention and information processing. Dr. Tannenbaum's findings support the recommendation issued in the Revised Beers Criteria published last spring 2012 by the American Geriatrics Society that all sleeping pills, 1st generation antihistamines and tricyclic antidepressants should be avoided at all costs in seniors.

    Dr. Tannenbaum believes in the importance of communicating this knowledge to patients: "Seniors can play an important role in reducing the risks associated with these medications. Patients need this information so that they are more comfortable talking to their doctors and pharmacists about safer pharmacological or non-pharmacological treatment options," she explained. She also points out that each case must be addressed on an individual basis: "Despite the known risks, it may be better for some patients to continue their medication instead of having to live with intolerable symptoms. Each individual has a right to make an informed choice based on preference and a thorough understanding of the effects the medications may have on their memory and function."

    ###

    Research summary

    MEDLINE and EMBASE were searched for randomized, double-blind, placebo-controlled trials of adults without underlying central nervous system disorders who underwent detailed neuropsychological testing prior to and after oral administration of drugs affecting cholinergic, histaminergic, GABAergic or opioid receptor pathways. Seventy-eight studies were identified, reporting 162 trials testing medication from the four targeted drug classes. Two investigators independently appraised study quality and extracted relevant data on the occurrence of amnestic, non-amnestic or combined cognitive deficits induced by each drug class. Only trials using validated neuropsychological tests were included. Quality of the evidence for each drug class was assessed based on consistency of results across trials and the presence of a dose-response gradient. This research was conducted in collaboration with researchers at the University of Sydney, the University of Calgary and the University of Iowa College of Public Health.

    About the author

    Cara Tannenbaum, MD, MSc, is a geriatrician and researcher in the health promotion, health care services and intervention unit at the Institut universitaire de griatrie de Montral (IUGM). She is also the inaugural Michel-Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging from the Faculty of Pharmacy at the Universit de Montral and an Associate Professor of Medicine at the Universit de Montral. She leads a program of research in epidemiologic and clinical geriatric health. Her clinical practice aims to improve medical care for older people.



    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    Is your memory playing tricks on you? Check your medicine cabinet! [ Back to EurekAlert! ] Public release date: 6-Nov-2012
    [ | E-mail | Share Share ]

    Contact: William Raillant-Clark
    w.raillant-clark@umontreal.ca
    514-343-7593
    University of Montreal

    National Senior Safety Week Drug safety for seniors

    This press release is available in French.

    Common medication to treat insomnia, anxiety, itching or allergies can have a negative impact on memory or concentration in the elderly, according to Dr. Cara Tannenbaum, Research Chair at the Institut universitaire de griatrie de Montral (IUGM, Montreal Geriatric University Institute) and Associate Professor of Medicine and Pharmacy at the University of Montreal (UdeM). Up to ninety percent of people over the age of 65 take at least one prescription medication. Eighteen percent of people in this age group complain of memory problems and are found to have mild cognitive deficits. Research suggests there may be a link between the two.

    Dr. Tannenbaum recently led a team of international researchers to investigate which medications are most likely to affect amnestic (memory) or non-amnestic (attention, concentration, performance) brain functions. After analyzing the results from 162 experiments on medications with potential to bind to cholinergic, histamine, GABAergic or opioid receptors in the brain, Dr. Tannenbaum concluded that the episodic use of several medications can cause amnestic or non-amnestic deficits. This potential cause is often overlooked in persons who are otherwise in good health.

    The 68 trials on benzodiazepines (which are often used to treat anxiety and insomnia) that were analyzed showed that these drugs consistently lead to impairments in memory and concentration, with a clear dose-response relationship. The 12 tests on antihistamines and the 15 tests on tricyclic antidepressants showed deficits in attention and information processing. Dr. Tannenbaum's findings support the recommendation issued in the Revised Beers Criteria published last spring 2012 by the American Geriatrics Society that all sleeping pills, 1st generation antihistamines and tricyclic antidepressants should be avoided at all costs in seniors.

    Dr. Tannenbaum believes in the importance of communicating this knowledge to patients: "Seniors can play an important role in reducing the risks associated with these medications. Patients need this information so that they are more comfortable talking to their doctors and pharmacists about safer pharmacological or non-pharmacological treatment options," she explained. She also points out that each case must be addressed on an individual basis: "Despite the known risks, it may be better for some patients to continue their medication instead of having to live with intolerable symptoms. Each individual has a right to make an informed choice based on preference and a thorough understanding of the effects the medications may have on their memory and function."

    ###

    Research summary

    MEDLINE and EMBASE were searched for randomized, double-blind, placebo-controlled trials of adults without underlying central nervous system disorders who underwent detailed neuropsychological testing prior to and after oral administration of drugs affecting cholinergic, histaminergic, GABAergic or opioid receptor pathways. Seventy-eight studies were identified, reporting 162 trials testing medication from the four targeted drug classes. Two investigators independently appraised study quality and extracted relevant data on the occurrence of amnestic, non-amnestic or combined cognitive deficits induced by each drug class. Only trials using validated neuropsychological tests were included. Quality of the evidence for each drug class was assessed based on consistency of results across trials and the presence of a dose-response gradient. This research was conducted in collaboration with researchers at the University of Sydney, the University of Calgary and the University of Iowa College of Public Health.

    About the author

    Cara Tannenbaum, MD, MSc, is a geriatrician and researcher in the health promotion, health care services and intervention unit at the Institut universitaire de griatrie de Montral (IUGM). She is also the inaugural Michel-Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging from the Faculty of Pharmacy at the Universit de Montral and an Associate Professor of Medicine at the Universit de Montral. She leads a program of research in epidemiologic and clinical geriatric health. Her clinical practice aims to improve medical care for older people.



    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    Source: http://www.eurekalert.org/pub_releases/2012-11/uom-iym110512.php

    philadelphia flyers 4/20 student loan forgiveness ufc 145 weigh ins record store day 2012 detroit red wings jose canseco